News Focus
News Focus
Replies to #73048 on Biotech Values
icon url

pastemp

02/11/09 8:38 PM

#73054 RE: DewDiligence #73048

The $21 million is not related to interferon lambda.It is a settlement for a patent dispute with BMY on a fusion technology.
icon url

iwfal

02/12/09 12:16 AM

#73072 RE: DewDiligence #73048

"As a calibration of my expectations, I give it an 80% chance of greater than $35M in 09Q1." It’s time to recalibrate: $35M is at the high end of what ZGEN expects for the entire year. The official full-year guidance is $25-35M:

Yep - I recanted after the earning last quarter (on some board, perhaps this one, perhaps not). I have to listen to the cc and look at my notes from last Q cc to update.

And just FYI from a completely naive calculation - if you assume that the increase was a ramp through the quarter then the run rate now is now about 5-6M per quarter. So the official full-year guidance is not a low ball - but neither is it very aggressive.